Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Bacterial Conjunctivitis: later-stage trial registry
1 of 8 indexed Bacterial Conjunctivitis trials are currently recruiting, with more weight in Phase 3-4.
Corpus placement: #2,176 of 28,707 conditions by registered trial count.
8 US clinical trials · 1 currently recruiting · #2,176 of 28,707 conditions by registered trial count
Bacterial Conjunctivitis: 8 US clinical trials tracked, 1 recruiting.
Bacterial Conjunctivitis is the subject of 8 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 7 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Alcon Research, running 3 of these trials.
Enrollment posture brief
Registry condition bacterial-conjunctivitis
OPEN 1 | RECR 13% | LATE 7 | EARLY 1 | RANK #2176 | SPON 3
Volume-matched condition peers
Nearest open-share peer: Acute Respiratory Infection (13% recruiting · 8 trials)
Bacterial Conjunctivitis lists 1 open slots (13% of 8 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Bacterial Conjunctivitis on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Bacterial Conjunctivitis is recruiting below its size-band peers.
1 of 8 indexed trials (12.5%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Bacterial Conjunctivitis research.
Alcon Research accounts for 3 of 8 trials (37.5%). 5 distinct sponsors appear on at least one study for this condition label.
-
Typical Bacterial Conjunctivitis enrolment sits around 685 participants.
Median target enrolment is 685 among the 8 trials that report a genuine target (sentinel values excluded). 1 of those (12.5%) plan for fewer than 100 participants.
-
Bacterial Conjunctivitis research is mostly interventional.
8 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
8 total, page 1 of 1
Efficacy of Fusidic Acid 1% in the Treatment of Bacterial Conjunctivitis
Baxis Pharmaceuticals
NCT06911424
Treatment of Bacterial Conjunctivitis With SHP640 Compared to PVP-Iodine and Placebo
Shire
NCT03004924
Evaluation of Clinical and Microbial Efficacy and Safety of AzaSite Compared to Tobramycin for Bacterial Conjunctivitis (C-01-401-004)
Merck Sharp & Dohme
NCT00105469
AL-15469A for the Treatment of Bacterial Conjunctivitis
Alcon Research
NCT00332293
Evaluation of Clinical and Microbial Efficacy and Safety of AzaSite Compared to Vehicle for Bacterial Conjunctivitis (C-01-401-003)
Merck Sharp & Dohme
NCT00105534
AL-15469A for the Treatment of Bacterial Conjunctivitis
Alcon Research
NCT00331916
Efficacy of Besifloxacin Ophthalmic Suspension in the Treatment of Bacterial Conjunctivitis
Bausch & Lomb Incorporated
NCT00972777
Study of the Progression of Bacterial Conjunctivitis Symptoms Upon Antibiotic Treatment
Alcon Research
NCT00798577
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 1 |
| Phase 3 | 6 |
| Phase 4 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Bacterial Conjunctivitis records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Bacterial Conjunctivitis trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Bacterial Conjunctivitis page
8 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 1 Bacterial Conjunctivitis trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Alcon Research sponsors the most Bacterial Conjunctivitis trials on record, review their full trial history before evaluating a specific study. See Alcon Research's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Bacterial Conjunctivitis condition card totals 8 registered trials; most-linked intervention AzaSite; top US site state Texas. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.